Endocrine Pharmaceuticals, Wilderness End, Tadley, Hampshire, United Kingdom.
Division of Nematology, ICAR-Indian Agricultural Research Institute, New Delhi, India.
PLoS One. 2022 Dec 1;17(12):e0278049. doi: 10.1371/journal.pone.0278049. eCollection 2022.
Biopurification has been used to disclose an evolutionarily conserved inhibitory reproductive hormone involved in tissue mass determination. A (rat) bioassay-guided physicochemical fractionation using ovine materials yielded via Edman degradation a 14-residue amino acid (aa) sequence. As a 14mer synthetic peptide (EPL001) this displayed antiproliferative and reproduction-modulating activity, while representing only a part of the native polypeptide. Even more unexpectedly, a scrambled-sequence control peptide (EPL030) did likewise.
Reproduction has been investigated in the nematode Steinernema siamkayai, using a fermentation system supplemented with different concentrations of exogenous hexapeptides. Peptide structure-activity relationships have also been studied using prostate cancer and other mammalian cells in vitro, with peptides in solution or immobilized, and via the use of mammalian assays in vivo and through molecular modelling.
Reproduction increased (x3) in the entomopathogenic nematode Steinernema siamkayai after exposure to one synthetic peptide (IEPVFT), while fecundity was reduced (x0.5) after exposure to another (KLKMNG), both effects being dose-dependent. These hexamers are opposite ends of the synthetic peptide KLKMNGKNIEPVFT (EPL030). Bioactivity is unexpected as EPL030 is a control compound, based on a scrambled sequence of the test peptide MKPLTGKVKEFNNI (EPL001). EPL030 and EPL001 are both bioinformatically obscure, having no convincing matches to aa sequences in the protein databases. EPL001 has antiproliferative effects on human prostate cancer cells and rat bone marrow cells in vitro. Intracerebroventricular infusion of EPL001 in sheep was associated with elevated growth hormone in peripheral blood and reduced prolactin. The highly dissimilar EPL001 and EPL030 nonetheless have the foregoing biological effects in common in mammalian systems, while being divergently pro- and anti-fecundity respectively in the nematode Caenorhabditis elegans. Peptides up to a 20mer have also been shown to inhibit the proliferation of human cancer and other mammalian cells in vitro, with reproductive upregulation demonstrated previously in fish and frogs, as well as nematodes. EPL001 encodes the sheep neuroendocrine prohormone secretogranin II (sSgII), as deduced on the basis of immunoprecipitation using an anti-EPL001 antibody, with bespoke bioinformatics. Six sSgII residues are key to EPL001's bioactivity: MKPLTGKVKEFNNI. A stereospecific bimodular tri-residue signature is described involving simultaneous accessibility for binding of the side chains of two specific trios of amino acids, MKP & VFN. An evolutionarily conserved receptor is conceptualised having dimeric binding sites, each with ligand-matching bimodular stereocentres. The bioactivity of the 14mer control peptide EPL030 and its hexapeptide progeny is due to the fortuitous assembly of subsets of the novel hormonal motif, MKPVFN, a default reproductive and tissue-building OFF signal.
生物净化已被用于揭示一种进化上保守的抑制性生殖激素,该激素参与组织质量的确定。使用来自绵羊的材料,通过 Edman 降解进行基于生物测定的物理化学分级分离,得到 14 个残基的氨基酸 (aa) 序列。作为 14 个残基的合成肽 (EPL001),它具有抗增殖和调节生殖的活性,而只是天然多肽的一部分。更令人惊讶的是,一个乱序对照肽 (EPL030) 也是如此。
使用补充了不同浓度外源性六肽的发酵系统,研究了线虫 Steinernema siamkayai 的生殖情况。还使用前列腺癌和其他哺乳动物细胞在体外进行了肽的结构-活性关系研究,包括肽在溶液或固定化中的情况,以及使用哺乳动物在体测定和通过分子建模。
暴露于一种合成肽 (IEPVFT) 后,昆虫病原线虫 Steinernema siamkayai 的生殖能力增加了 3 倍,而暴露于另一种肽 (KLKMNG) 后生殖能力降低了 0.5 倍,这两种作用都是剂量依赖性的。这两种六肽是合成肽 KLKMNGKNIEPVFT (EPL030) 的两端。EPL030 是一种对照化合物,基于测试肽 MKPLTGKVKEFNNI (EPL001) 的乱序序列,因此具有生物活性是出乎意料的。EPL030 和 EPL001 在生物信息学上都很模糊,与蛋白质数据库中的氨基酸序列没有令人信服的匹配。EPL001 对人前列腺癌细胞和大鼠骨髓细胞具有抗增殖作用。在绵羊中脑室内输注 EPL001 与外周血中生长激素升高和催乳素降低有关。高度不同的 EPL001 和 EPL030 尽管在哺乳动物系统中具有上述生物学作用,但在秀丽隐杆线虫中分别具有促进和抑制生殖的作用。已证明长达 20 个残基的肽也能抑制人癌症和其他哺乳动物细胞的增殖,以前在鱼类和青蛙以及线虫中也证明了生殖的上调。EPL001 编码绵羊神经内分泌前激素分泌颗粒 II (sSgII),这是基于使用抗 EPL001 抗体进行免疫沉淀推断出来的,采用了定制的生物信息学方法。六个 sSgII 残基是 EPL001 生物活性的关键:MKPLTGKVKEFNNI。描述了一个立体特异性双模块三残基特征,涉及同时可用于结合两个特定三肽的侧链的结合,MKP 和 VFN。概念化了一个进化上保守的受体,具有二聚体结合位点,每个位点都具有配体匹配的双模块立体中心。14 个残基对照肽 EPL030 及其六肽后代的生物活性归因于新型激素基序的亚组的偶然组装,MKPVFN 是默认的生殖和组织构建关闭信号。